CLINICAL TRIAL: EFFECTS OF COENZYME Q10 IN PARKINSON DISEASE (QE#)

临床试验：辅酶 Q10 对帕金森病 (QE

• 批准号: 8167263
• 负责人: ANDREW FEIGIN
• 金额: $ 1.4万
• 依托单位: FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH
• 依托单位国家: 美国
• 财政年份: 2010
• 资助国家: 美国
• 起止时间: 2010-04-01 至 2011-03-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8167263
• 关键词: Asses; Clinical Trials; Coenzyme Q10; Computer Retrieval of Information on Scientific Projects Database; Creatine; Dose; Funding; Grant; Impairment; Institution; Parkinson Disease; Patients; Placebos; Research; Research Personnel; Resources; Source; United States National Institutes of Health

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. This is a 16-month study to asses the effects of creatine (two doses) versus placebo on slowing the progressive impairment of Parkinson's disease in early untreated patients.

这个子项目是许多研究子项目中的一个 由NIH/NCRR资助的中心赠款提供的资源。子项目和 研究者（PI）可能从另一个NIH来源获得了主要资金， 因此可以在其他CRISP条目中表示。所列机构为 研究中心，而研究中心不一定是研究者所在的机构。 这是一项为期16个月的研究，旨在评估肌酸（两种剂量）与安慰剂对减缓早期未经治疗的帕金森病患者进行性损害的影响。